SI-BONE, Inc. (SIBN)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$24.95+4.96%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · SIBN
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 6.5% |
| Our one-year growth estimate | diamond | 18.4% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 11.8 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 28 industry peers · Company calendar date is not available
SIBN — capital allocation — Creation of a Direct Financial Obligation or an Obligation under an Off-Balan…
Dated 2026-09-11
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in “
Why it matters: Gross margin was 79.5% in Q2. A sharp drop could make it harder to meet the full-year goal.
Worry ifQ3 gross margin falls below 78%, or management lowers its full-year gross margin goal below 79%.
Less concerning ifQ3 gross margin stays at or above 79%, and management keeps the full-year goal near 79%.
Why it matters: The company raised its 2026 revenue range after Q2 growth of 15.2%. Q3 results will test whether that pace continues.
Supportive ifQ3 worldwide revenue grows at least 15% year over year, and management keeps or raises the $231M-$233M 2026 range.
Worry ifQ3 worldwide revenue grows less than 10% year over year, or management cuts the 2026 range below $231M.
Why it matters: Management pointed to a Q4 launch as a way to reach more patients. The launch and early use will show whether the new device adds to growth.
Supportive ifThe company announces a Q4 launch. It then reports physician use or more procedures.
Worry ifThe launch slips past Q4, or the company reports no physician use after launch.
Why it matters: The company recalled implants from some lots after packages failed sterility checks. A wider recall or supply pause could disrupt sales.
Worry ifThe company reports more affected lots, more than 98 implants recalled, or a pause in iFuse TORQ shipments.
Less concerning ifThe recall remains limited to the 98 implants, with no added lots or shipment pause disclosed.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$180 on $10,000 · ±1.8% | How much price usually moves either way. |
| Bad day | $430 loss on $10,000 · 4.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,575 loss on $10,000 · 45.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.